Advertisement

Topics

Companies Related to "Expansion Therapeutics" [Most Relevant Company Matches] [Advanced Search Results] RSS

16:05 EDT 20th March 2019 | BioPortfolio

Here are the most relevant search results for "Expansion Therapeutics" found in our extensive corporate database of over 50,000 company records.

Showing "Expansion Therapeutics" Companies 1–25 of 1,900+

Relevant

Expansion Therapeutics, Inc.

Expansion Therapeutics is a drug discovery and development company pursuing the vast potential of small molecule medicines for RNA-mediated diseases. Based on exclusive worldwide rights to groundbreaking research from the laboratory of Matthew D. Disney, Ph.D., at The Scripps Research Institute, Expansion has assembled the intellectual property, know-how, ...


Parvus Therapeutics

Parvus Therapeutics Inc. is a privately held biopharmaceutical company engaged in the development and commercialization of Navacim therapeutics, novel nanoparticle based immune complexes that induce the in-vivo expansion of disease-specific T- and B-regulatory cells resulting in the restoration of immune homeostasis. Navacims can be readily be tailored to ...

Parvus Therapeutics Inc.

Parvus Therapeutics Inc. is a privately-held biopharmaceutical company engaged in the development and commercialization of Navacim therapeutics, novel nanoparticle based immune complexes that induce the in vivo expansion of specific regulatory cells resulting in the restoration of immune homeostasis. Navacims can be readily tailored to target a broad range...


Phoenix Children’s Hospital

Phoenix Children’s Hospital, ranked in U.S. News & World Report’s Best Children’s Hospitals, is Arizona’s only licensed children’s hospital, providing world-class care in more than 40 pediatric specialties to children from throughout the state and region. Phoenix Children’s expansion has met the needs of the Southwest’s rapid ...

Probably Relevant

VGTI Florida

VGTI Florida is the Florida-funded expansion of Oregon Health & Science University's highly successful Vaccine and Gene Therapy Institute. Research at the facility will focus on vaccine development with a special focus on vaccines and therapeutics that protect the aging population, which is the most vulnerable to disease.

Nohla Therapeutics Inc.

Nohla’s goal is to transform the medical care options for patients with our expanded cord blood product. The proprietary expansion platform multiplies the number of stem cells found in cord blood donations up to 500 times. This landmark advance made cord blood a viable alternative to adult bone marrow in the transplant setting.

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other advanced lung diseases. Founded in 2001, Aeris Therapeutics is privately held, with corporate offices in Woburn, MA.

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therapeutics’ lead product is AIR645, the first in a new class of inhaled drugs that incorporate proprietary, second-generation antisense chemistry. www.altairthera.com

Vaxiion Therapeutics, Inc.

Vaxiion is dedicated to the design and development of intelligent drug-delivery technologies with special emphasis on targeted oncology therapeutics. Vaxiion Therapeutics was spun out of Lpath, Inc. by Dr. Roger Sabbadini in 2000. For more information about Vaxiion Therapeutics visit www.vaxiion.com

Vesta Therapeutics, Inc

Vesta Therapeutics is a privately held company developing cell therapeutics for liver repair and regeneration. The Company's technology is centered on the isolation, expansion, and cryopreservation of liver cells (human hepatocytes) obtained from organ donor livers that are not suitable for whole organ transplantation. Clinicians in academic settings have found that, following administration, huma...

Click Therapeutics, Inc.

Click Therapeutics, Inc. engineers, validates, and commercializes Digital Therapeutics™ solutions to benefit people with unmet medical needs through cognitive and neurobehavioral modification. Click Therapeutics™ digital interventions enable change within individuals, and can be used independently or in conjunction with biomedical treatments. The...

Nexell Therapeuitcs Incorporated

Nexell Therapeutics Inc.(NASDAQ: NEXL), formerly known as VIMRX Pharmaceuticals Inc., is the leading developer and marketer of innovative diagnostics and ex vivo cell therapies for cancer, autoimmune, metabolic and genetic diseases. Nexell’s lead product, the Isolex® Cell Selection System, is marketed in a number of countries and is currently under final review by the FDA in the United States....

United Therapeutics

United Therapeutics is a biotechnology company focused on the development and commercialization of unique products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases. In these segments, United Therapeutics is actively developing four technology platforms: Prostacyclin Analogs, Immunotherapeutic Monoclonal Antibodies, Glycobiology, and Telemedicine. At Un...

Pop Test Cortisol LLC

Pop Test Cortisol LLC is part of the Pop Test group of companies. Pop Test was founded in 2008 with the creation of the saliva based diabetes testing platform planned for launch with Walmart in 2012. The company has since developed a series of diagnostic platforms including the saliva Pop Test devices and lateral flow diagnostics for biological and agricul...

BBB Therapeutics

BBB Therapeutics is pioneering innovative therapeutics to treat severe brain disorders for which there are currently limited treatment options. We are advancing a clinical pipeline of product candidates initially focused on treating brain metastases and primary brain tumors as well as indications in neuroinflammation. Our proprietary liposomal G-Technology...

Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc., started by the founders of Vicept Therapeutics, is a privately held specialty pharmaceutical dermatology company focused on the development of novel dermatologic therapies. Visit www.aclaristx.com for more information.

KPI Therapeutics, Inc.

KPI Therapeutics is a development and funding consortium aimed at moving a diversified portfolio of novel drug programs into the clinic so they can be partnered for new medicines. KPI’s objective is to become a self-sustaining company with a robust pipeline of therapeutics through revenue from portfolio investments.

Auven Therapeutics

Auven Therapeutics is a private equity company focused on the healthcare industry. The Company’s strategy is to acquire controlling ownership in promising therapeutic products or platforms. The value of these therapeutic assets is then significantly enhanced by global development programs prior to selling them as clinically and commercially validated products to established pharmaceutica...

Zelos Therapeutics, Inc.

Zelos Therapeutics specializes in the development of innovative treatments for bone disorders and related indications in large, underserved markets. Led by an experienced team of biopharmaceutical executives and funded by leading health care investors, Zelos Therapeutics is advancing a portfolio of product opportunities into late stage clinical development...

Makefield Therapeutics, Inc.

Makefield Therapeutics, Inc., founded in July 2009, is a privately held therapeutics company with two development programs addressing large market opportunities in anti-infectives and the treatment of erectile dysfunction. Both programs are based on an innovative nanoparticle drug delivery platform with the potential to generate a pipeline of additional no...

NKT Therapeutics, Inc.

NKT Therapeutics, Inc. is a privately held biotechnology company focused on developing therapeutics based on unique immune cells called natural killer T (NKT) cells. The company’s mission is to use its expertise to develop a pipeline of first-in-class NKT-based therapeutics to treat autoimmune and inflammatory diseases, cancer, infectious diseases, and ...

Seres Therapeutics Inc.

Seres Therapeutics Inc. is a leading microbiome therapeutics platform company developing a novel class of biological drugs that are designed to treat disease by restoring the function of a dysbiotic microbiome.

Seres Therapeutics, Inc.

Seres Therapeutics, Inc. is a leading microbiome therapeutics platform company developing a novel class of biological drugs that are designed to treat disease by restoring the function of a dysbiotic microbiome.

Elstar Therapeutics, Inc.

Elstar Therapeutics is fulfilling the promise of precision cancer immunotherapy through a powerful new approach to generating antibody-based, multi-functional therapeutics.

Maverick Therapeutics Inc.

Maverick Therapeutics is pioneering the next generation of redirected T cell therapeutics in immuno-oncology. Maverick’s highly innovative platform is designed to deliver potent activity with increased tumor specificity and reduced toxicity, resulting in superior therapeutics for cancer patients and improved clinical success. Maverick was founded by M...


More From BioPortfolio on "Expansion Therapeutics"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks